Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs

by

As part of a new strategic collaboration with KAEDI Biotech Inc., Porton Biologics Ltd. will provide KAEDI with CMC services for CAR-T projects with its end-to-end CDMO platform, to help accelerate development.  The results of the companies’ first project in collaboration, KD-025 CAR-T, have been published and there is an ongoing multi-centre clinical trial of […]

Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows

Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows

by

Researchers at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam, conducted a randomized clinical trial examining the safety and therapeutic potential of autologous bone marrow stem cells, finding that non-obese patients who have had the disease for less than a decade are most likely to benefit from the treatment.  The study […]

Non-altered birth cord cells boost survival of critically ill COVID-19 patients

Non-altered birth cord cells boost survival of critically ill COVID-19 patients

by

A clinical trial was launched last year in Jakarta, Indonesia, after the COVID-19 occupancy rate in the city’s ICUs and mortality rate of critically ill COVID-19 pneumonia patients hit alarmingly high numbers. The study showed that treatment with non-altered stem cells from umbilical cord connective tissue doubled chances of survival in these patients, and increased […]

bag